BUSINESS COMBINATIONS - Narrative (Details) - USD ($) $ in Millions				3 Months Ended	9 Months Ended
	Aug. 19, 2024	Aug. 18, 2024	Jul. 22, 2024	Sep. 30, 2024	Sep. 30, 2024
Endotronix, Inc
Business Acquisition [Line Items]
Cash consideration paid at closing	$ 650.3	$ 60.0
Fair value of previously held equity interest	$ 94.6	$ 10.0
Percentage of previously held interest		7.00%
Equity interest in acquire, excluding initial acquisition, percentage	93.00%
Step acquisition, equity interest in acquire, remeasurement gain				$ 24.6
Total purchase price, net of cash acquired	$ 798.8
Payments to acquire businesses	649.1
Less: cash acquired	(1.2)
Settlement of pre-existing relationships	53.1
Contingent consideration liabilities	2.0
Business combination, escrow deposit				$ 35.0	$ 35.0
Acquisition-related costs					5.6
In-process research and development, expected costs	$ 47.1
Endotronix, Inc | Developed technology | Discount Rate
Business Acquisition [Line Items]
Measurement input	15.50%
Endotronix, Inc | In-process research and development | Discount Rate
Business Acquisition [Line Items]
Measurement input	18.00%
JC Medical, Inc
Business Acquisition [Line Items]
Cash consideration paid at closing			$ 114.8
Total purchase price, net of cash acquired			116.3
Less: cash acquired			(0.3)
Contingent consideration liabilities			1.8
Business combination, escrow deposit			12.0
Acquisition-related costs					$ 1.6
In-process research and development, expected costs	$ 55.8
Additional contingent consideration			$ 200.0
Contingent consideration liability, term			12 years
Escrow deposit, holding period			15 months
JC Medical, Inc | In-process research and development | Discount Rate
Business Acquisition [Line Items]
Measurement input			15.00%